CIGLIANO, Antonio
CIGLIANO, Antonio
MEDICINA, CHIRURGIA E FARMACIA
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis
2017-01-01 Liu, Pin; Ge, Mengmeng; Hu, Junjie; Li, Xiaolei; Che, Li; Sun, Kun; Cheng, Lili; Huang, Yuedong; Pilo, Maria G; Cigliano, Antonio; Pes, Giovanni M; Pascale, Rosa M; Brozzetti, Stefania; Vidili, Gianpaolo; Porcu, Alberto; Cossu, Antonio; Palmieri, Giuseppe; Sini, Maria C; Ribback, Silvia; Dombrowski, Frank; Tao, Junyan; Calvisi, Diego F; Chen, Ligong; Chen, Xin
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1
2009-01-01 Lepedda, Antonio Junior; Cigliano, A; Cherchi, Gm; Spirito, R; Maggioni, M; Carta, F; Turrini, F; Edelstein, C; Scanu, Am; Formato, Marilena
Aortic and pulmonary bioprosthetic heart valves: an insight on glycosaminoglycan distribution and fine structure in decellularized porcine scaffolds for tissue engineering purposes
2009-02-24 Cigliano, Antonio
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque
2012-01-01 Zinellu, E; Lepedda, Antonio Junior; Cigliano, A; Pisanu, S; Zinellu, Angelo; Carru, Ciriaco; Bacciu, Pp; Piredda, F; Guarino, A; Spirito, R; Formato, Marilena
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
2017-01-01 Cao, Dan; Song, Xinhua; Che, Li; Li, Xiaolei; Pilo, Maria G.; Vidili, Gianpaolo; Porcu, Alberto; Solinas, Antonio; Cigliano, Antonio; Pes, Giovanni M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Li, Lei; Calvisi, Diego F.
Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma
2020-01-01 Shang, R.; Song, X.; Wang, P.; Zhou, Y.; Lu, X.; Wang, J.; Xu, M.; Chen, X.; Utpatel, K.; Che, L.; Liang, B.; Cigliano, A.; Evert, M.; Calvisi, D. F.; Chen, X.
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
2022-01-01 Mancarella, S.; Serino, G.; Gigante, I.; Cigliano, A.; Ribback, S.; Sanese, P.; Grossi, V.; Simone, C.; Armentano, R.; Evert, M.; Calvisi, D. F.; Giannelli, G.
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
2017-01-01 Liu, P.; Calvisi, D. F.; Kiss, A.; Cigliano, A.; Schaff, Z.; Che, L.; Ribback, S.; Dombrowski, F.; Zhao, D.; Chen, X.
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
2019-01-01 Che, Li; Chi, Wenna; Qiao, Yu; Zhang, Jie; Song, Xinhua; Liu, Ye; Li, Lei; Jia, Jiaoyuan; Pilo, Maria G.; Wang, Jingxiao; Cigliano, Antonio; Ma, Zhilong; Kuang, Wenhua; Tang, Zefang; Zhang, Zemin; Shui, Guanghou; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Pascale, Rosa Maria; Cossu, Carla; Pes, Giovanni Mario; Osborne, Timothy F.; Calvisi, Diego F.; Chen, Xin; Chen, Ligong
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
2016-01-01 Hu, Junjie; Che, Li; Li, Lei; Pilo, Maria Giulia; Cigliano, Antonio; Ribback, Silvia; Li, Xiaolei; Latte, Gavinella; Mela, Marta; Evert, Matthias; Dombrowski, Frank; Zheng, Guohua; Chen, Xin; Calvisi, Diego Francesco
Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma
2019-01-01 Song, X.; Liu, X.; Wang, H.; Wang, J.; Qiao, Y.; Cigliano, A.; Utpatel, K.; Ribback, S.; Pilo, M. G.; Serra, M.; Gordan, J. D.; Che, L.; Zhang, S.; Cossu, A.; Porcu, A.; Pascale, R. M.; Dombrowski, F.; Hu, H.; Calvisi, D. F.; Evert, M.; Chen, X.
Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021))
2022-01-01 Wang, H.; Zhang, S.; Zhang, Y.; Jia, J.; Wang, J.; Liu, X.; Zhang, J.; Song, X.; Ribback, S.; Cigliano, A.; Evert, M.; Liang, B.; Wu, H.; Calvisi, D. F.; Zeng, Y.; Chen, X.
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
2020-01-01 Mancarella, S.; Serino, G.; Dituri, F.; Cigliano, A.; Ribback, S.; Wang, J.; Chen, X.; Calvisi, D. F.; Giannelli, G.
Current challenges to underpinning the genetic basis for cholangiocarcinoma
2021-01-01 Cigliano, A.; Chen, X.; Calvisi, D. F.
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
2017-01-01 Cigliano, Antonio; Pilo, Maria G.; Li, Lei; Latte, Gavinella; Szydlowska, Marta; Simile, Maria M.; Paliogiannis, Panagiotis; Che, Li; Pes, Giovanni M.; Palmieri, Giuseppe; Sini, Maria C.; Cossu, Antonio; Porcu, Alberto; Vidili, Gianpaolo; Seddaiu, Maria A.; Pascale, Rosa M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Calvisi, Diego F.
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
2016-01-01 Li, Lei; Che, Li; Tharp, Kevin M.; Park, Hyo Min; Pilo, Maria Giulia; Cao, Dan; Cigliano, Antonio; Latte, Gavinella; Xu, Zhong; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Gores, Gregory J.; Stahl, Andreas; Calvisi, Diego Francesco; Chen, Xin
Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
2021-01-01 Wang, Haichuan; Wang, Jingxiao; Zhang, Shanshan; Jia, Jiaoyuan; Liu, Xianqiong; Zhang, Jie; Wang, Pan; Song, Xinhua; Che, Li; Liu, Ke; Ribback, Silvia; Cigliano, Antonio; Evert, Matthias; Wu, Hong; F Calvisi, Diego; Zeng, Yong; Chen, Xin
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
2018-01-01 Dong, M.; Liu, X.; Evert, K.; Utpatel, K.; Peters, M.; Zhang, S.; Xu, Z.; Che, L.; Cigliano, A.; Ribback, S.; Dombrowski, F.; Cossu, A.; Gordan, J.; Calvisi, D. F.; Evert, M.; Liu, Y.; Chen, X.
Erratum: Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer (Journal of Oncology (2019) 2019 (2715968) DOI: 10.1155/2019/2715968)
2020-01-01 Scavo, M. P.; Cigliano, A.; Depalo, N.; Fanizza, E.; Bianco, M. G.; Denora, N.; Laquintana, V.; Curri, M. L.; Lorusso, D.; Lotesoriere, C.; Panarese, A.; Giannelli, G.
Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma
2018-01-01 Liu, X.; Song, X.; Zhang, J.; Xu, Z.; Che, L.; Qiao, Y.; Ortiz Pedraza, Y.; Cigliano, A.; Pascale, R. M.; Calvisi, D. F.; Liu, Y.; Chen, X.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis | 1-gen-2017 | Liu, Pin; Ge, Mengmeng; Hu, Junjie; Li, Xiaolei; Che, Li; Sun, Kun; Cheng, Lili; Huang, Yuedong; Pilo, Maria G; Cigliano, Antonio; Pes, Giovanni M; Pascale, Rosa M; Brozzetti, Stefania; Vidili, Gianpaolo; Porcu, Alberto; Cossu, Antonio; Palmieri, Giuseppe; Sini, Maria C; Ribback, Silvia; Dombrowski, Frank; Tao, Junyan; Calvisi, Diego F; Chen, Ligong; Chen, Xin | |
| A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 | 1-gen-2009 | Lepedda, Antonio Junior; Cigliano, A; Cherchi, Gm; Spirito, R; Maggioni, M; Carta, F; Turrini, F; Edelstein, C; Scanu, Am; Formato, Marilena | |
| Aortic and pulmonary bioprosthetic heart valves: an insight on glycosaminoglycan distribution and fine structure in decellularized porcine scaffolds for tissue engineering purposes | 24-feb-2009 | Cigliano, Antonio | |
| Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque | 1-gen-2012 | Zinellu, E; Lepedda, Antonio Junior; Cigliano, A; Pisanu, S; Zinellu, Angelo; Carru, Ciriaco; Bacciu, Pp; Piredda, F; Guarino, A; Spirito, R; Formato, Marilena | |
| Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells | 1-gen-2017 | Cao, Dan; Song, Xinhua; Che, Li; Li, Xiaolei; Pilo, Maria G.; Vidili, Gianpaolo; Porcu, Alberto; Solinas, Antonio; Cigliano, Antonio; Pes, Giovanni M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Li, Lei; Calvisi, Diego F. | |
| Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma | 1-gen-2020 | Shang, R.; Song, X.; Wang, P.; Zhou, Y.; Lu, X.; Wang, J.; Xu, M.; Chen, X.; Utpatel, K.; Che, L.; Liang, B.; Cigliano, A.; Evert, M.; Calvisi, D. F.; Chen, X. | |
| CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype | 1-gen-2022 | Mancarella, S.; Serino, G.; Gigante, I.; Cigliano, A.; Ribback, S.; Sanese, P.; Grossi, V.; Simone, C.; Armentano, R.; Evert, M.; Calvisi, D. F.; Giannelli, G. | |
| Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development | 1-gen-2017 | Liu, P.; Calvisi, D. F.; Kiss, A.; Cigliano, A.; Schaff, Z.; Che, L.; Ribback, S.; Dombrowski, F.; Zhao, D.; Chen, X. | |
| Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans | 1-gen-2019 | Che, Li; Chi, Wenna; Qiao, Yu; Zhang, Jie; Song, Xinhua; Liu, Ye; Li, Lei; Jia, Jiaoyuan; Pilo, Maria G.; Wang, Jingxiao; Cigliano, Antonio; Ma, Zhilong; Kuang, Wenhua; Tang, Zefang; Zhang, Zemin; Shui, Guanghou; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Pascale, Rosa Maria; Cossu, Carla; Pes, Giovanni Mario; Osborne, Timothy F.; Calvisi, Diego F.; Chen, Xin; Chen, Ligong | |
| Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice | 1-gen-2016 | Hu, Junjie; Che, Li; Li, Lei; Pilo, Maria Giulia; Cigliano, Antonio; Ribback, Silvia; Li, Xiaolei; Latte, Gavinella; Mela, Marta; Evert, Matthias; Dombrowski, Frank; Zheng, Guohua; Chen, Xin; Calvisi, Diego Francesco | |
| Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma | 1-gen-2019 | Song, X.; Liu, X.; Wang, H.; Wang, J.; Qiao, Y.; Cigliano, A.; Utpatel, K.; Ribback, S.; Pilo, M. G.; Serra, M.; Gordan, J. D.; Che, L.; Zhang, S.; Cossu, A.; Porcu, A.; Pascale, R. M.; Dombrowski, F.; Hu, H.; Calvisi, D. F.; Evert, M.; Chen, X. | |
| Corrigendum to ‘TAZ is indispensable for c-MYC-induced hepatocarcinogenesis’ [J Hepatol (2022) 123–134] (Journal of Hepatology (2022) 76(1) (123–134), (S016882782102016X), (10.1016/j.jhep.2021.08.021)) | 1-gen-2022 | Wang, H.; Zhang, S.; Zhang, Y.; Jia, J.; Wang, J.; Liu, X.; Zhang, J.; Song, X.; Ribback, S.; Cigliano, A.; Evert, M.; Liang, B.; Wu, H.; Calvisi, D. F.; Zeng, Y.; Chen, X. | |
| Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis | 1-gen-2020 | Mancarella, S.; Serino, G.; Dituri, F.; Cigliano, A.; Ribback, S.; Wang, J.; Chen, X.; Calvisi, D. F.; Giannelli, G. | |
| Current challenges to underpinning the genetic basis for cholangiocarcinoma | 1-gen-2021 | Cigliano, A.; Chen, X.; Calvisi, D. F. | |
| Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis | 1-gen-2017 | Cigliano, Antonio; Pilo, Maria G.; Li, Lei; Latte, Gavinella; Szydlowska, Marta; Simile, Maria M.; Paliogiannis, Panagiotis; Che, Li; Pes, Giovanni M.; Palmieri, Giuseppe; Sini, Maria C.; Cossu, Antonio; Porcu, Alberto; Vidili, Gianpaolo; Seddaiu, Maria A.; Pascale, Rosa M.; Ribback, Silvia; Dombrowski, Frank; Chen, Xin; Calvisi, Diego F. | |
| Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans | 1-gen-2016 | Li, Lei; Che, Li; Tharp, Kevin M.; Park, Hyo Min; Pilo, Maria Giulia; Cao, Dan; Cigliano, Antonio; Latte, Gavinella; Xu, Zhong; Ribback, Silvia; Dombrowski, Frank; Evert, Matthias; Gores, Gregory J.; Stahl, Andreas; Calvisi, Diego Francesco; Chen, Xin | |
| Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. | 1-gen-2021 | Wang, Haichuan; Wang, Jingxiao; Zhang, Shanshan; Jia, Jiaoyuan; Liu, Xianqiong; Zhang, Jie; Wang, Pan; Song, Xinhua; Che, Li; Liu, Ke; Ribback, Silvia; Cigliano, Antonio; Evert, Matthias; Wu, Hong; F Calvisi, Diego; Zeng, Yong; Chen, Xin | |
| Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model | 1-gen-2018 | Dong, M.; Liu, X.; Evert, K.; Utpatel, K.; Peters, M.; Zhang, S.; Xu, Z.; Che, L.; Cigliano, A.; Ribback, S.; Dombrowski, F.; Cossu, A.; Gordan, J.; Calvisi, D. F.; Evert, M.; Liu, Y.; Chen, X. | |
| Erratum: Frizzled-10 extracellular vesicles plasma concentration is associated with tumoral progression in patients with colorectal and gastric cancer (Journal of Oncology (2019) 2019 (2715968) DOI: 10.1155/2019/2715968) | 1-gen-2020 | Scavo, M. P.; Cigliano, A.; Depalo, N.; Fanizza, E.; Bianco, M. G.; Denora, N.; Laquintana, V.; Curri, M. L.; Lorusso, D.; Lotesoriere, C.; Panarese, A.; Giannelli, G. | |
| Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma | 1-gen-2018 | Liu, X.; Song, X.; Zhang, J.; Xu, Z.; Che, L.; Qiao, Y.; Ortiz Pedraza, Y.; Cigliano, A.; Pascale, R. M.; Calvisi, D. F.; Liu, Y.; Chen, X. |